{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:05:57Z","timestamp":1790471157812,"version":"4.1.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,15]]},"DOI":"10.2146\/ajhp120119","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T16:55:47Z","timestamp":1386003347000},"page":"2185-2198","source":"Crossref","is-referenced-by-count":37,"title":["Stability and compatibility of antimicrobial lock solutions"],"prefix":"10.1093","volume":"70","author":[{"given":"P. Brandon","family":"Bookstaver","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy (SCCP), University of South Carolina Campus, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E. E.","family":"Rokas","sequence":"additional","affiliation":[{"name":"Postgraduate Year 2 Infectious Diseases Resident, Department of Pharmacy, Wake Forest Baptist Health, Winston-Salem, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeAnn B.","family":"Norris","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Outcomes Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Pharm.D. candidate, SCCP, University of South Carolina Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Sherertz","sequence":"additional","affiliation":[{"name":"School of Medicine, Wake Forest University, Winston-Salem"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"9","key":"key\n\t\t\t\t2019031208581902900_b1-0702185","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b2-0702185","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.43.9.2200","article-title":"Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer","volume":"43","author":"Carratala","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b3-0702185","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1542\/peds.2004-2674","article-title":"A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial","volume":"116","author":"Garland","year":"2005","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019031208581902900_b4-0702185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.ki.5000012","article-title":"Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial","volume":"69","author":"Kim","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019031208581902900_b5-0702185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1542-4758.2010.00440.x","article-title":"Antibiotic lock: in vitro stability of gentamicin and sodium citrate in dialysis catheters at 37 degrees C","volume":"14","author":"Battistella","year":"2010","journal-title":"Hemodial Int"},{"key":"key\n\t\t\t\t2019031208581902900_b6-0702185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1542-4758.2009.00368.x","article-title":"Antibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees C","volume":"13","author":"Battistella","year":"2009","journal-title":"Hemodial Int"},{"key":"key\n\t\t\t\t2019031208581902900_b7-0702185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2146\/ajhp090505","article-title":"Physical compatability of 4% sodium citrate with selected antimicrobial agents","volume":"67","author":"Dotson","year":"2010","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b8-0702185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4212\/cjhp.v63i4.934","article-title":"Stability of Trisodium Citrate and Gentamicin Solution for Catheter Locks after Storage in Plastic Syringes at Room Temperature","volume":"63","author":"Cote","year":"2010","journal-title":"Can J Hosp Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b9-0702185","volume-title":"Evaluation of compatibility and stability of daptomycin in an antibiotic-anticoagulant lock solution","author":"Bookstaver"},{"key":"key\n\t\t\t\t2019031208581902900_b10-0702185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jhin.2011.07.010","article-title":"Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization","volume":"79","author":"Shenep","year":"2011","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t2019031208581902900_b11-0702185","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jac\/dkn291","article-title":"Effectiveness of a 30% ethanol\/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections","volume":"62","author":"Takla","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b12-0702185","volume-title":"Trissel\u2019s 2 clinical pharmaceutics database [electronic database]","author":"Trissel"},{"key":"key\n\t\t\t\t2019031208581902900_b13-0702185","first-page":"1569","article-title":"Stability studies: five years later","volume":"45","author":"Trissel","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b14-0702185","first-page":"1159","article-title":"Avoiding common flaws in stability and compatibility studies of injectable drugs","volume":"40","author":"Trissel","year":"1983","journal-title":"Am J Hosp Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b15-0702185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1345\/aph.1L145","article-title":"Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections","volume":"43","author":"Bookstaver","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019031208581902900_b16-0702185","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkl103","article-title":"Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study","volume":"57","author":"Fernandez-Hidalgo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b17-0702185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1592\/phco.22.1.105.33507","article-title":"Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock","volume":"22","author":"Saxena","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"2","key":"key\n\t\t\t\t2019031208581902900_b18-0702185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0195-6701(92)90094-3","article-title":"A new approach to the management of Broviac catheter infection","volume":"22","author":"Rao","year":"1992","journal-title":"J Hosp Infect"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b19-0702185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10096-005-1291-0","article-title":"Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters","volume":"24","author":"S\u00e1nchez-Mu\u00f1oz","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b20-0702185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkg179","article-title":"Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis","volume":"51","author":"Droste","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b21-0702185","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/652153","article-title":"Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants","volume":"31","author":"Polgreen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019031208581902900_b22-0702185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkf183","article-title":"Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis","volume":"50","author":"Bailey","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b23-0702185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000324685","article-title":"Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial","volume":"33","author":"Filiopoulos","year":"2011","journal-title":"Am J Nephrol"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b24-0702185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1592\/phco.20.5.394.35063","article-title":"Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter","volume":"20","author":"Vercaigne","year":"2000","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019031208581902900_b25-0702185","article-title":"Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin","author":"Silva","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"key\n\t\t\t\t2019031208581902900_b26-0702185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2011.08.031","article-title":"A randomized trial comparing gentamicin\/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients","volume":"59","author":"Moran","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"key\n\t\t\t\t2019031208581902900_b27-0702185","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1128\/AAC.01606-12","article-title":"Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy","volume":"56","author":"Chauhan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"key\n\t\t\t\t2019031208581902900_b28-0702185","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.01270210","article-title":"Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis","volume":"5","author":"Landry","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019031208581902900_b29-0702185","first-page":"308","article-title":"Prophylaxis with gentamicin locking of chronic tunnelled central venous catheters does not cause bacterial resistance","volume":"31","author":"Fern\u00e1ndez-Gallego","year":"2011","journal-title":"Nefrologia"},{"key":"key\n\t\t\t\t2019031208581902900_b30-0702185","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/ndt\/gfn023","article-title":"Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia","volume":"23","author":"Onder","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b31-0702185","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2215\/CJN.04931107","article-title":"Comparison of early versus late use of antibiotic lock in the treatment of catheter-related bacteremia","volume":"3","author":"Onder","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"key\n\t\t\t\t2019031208581902900_b32-0702185","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00467-009-1235-5","article-title":"Prophylaxis of catheter related bacteremia using tissue plasminogen activator-tobramycin locks","volume":"24","author":"Onder","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t2019031208581902900_b33-0702185","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/AAC.43.8.2074","article-title":"Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports)","volume":"43","author":"Anthony","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b34-0702185","first-page":"346","article-title":"Compatibility and stability of cefotaxime, vancomycin, and ciprofloxacin in antibiotic lock solutions containing heparin","volume":"14","author":"Baker","year":"2010","journal-title":"Int J Pharmaceutical Compound"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b35-0702185","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/AAC.45.5.1565-1567.2001","article-title":"Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock techniques","volume":"45","author":"Haimi-Cohen","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b36-0702185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/49.4.693","article-title":"An in vitro evaluation of the antibiotic\/heparin lock to sterilize central venous haemodialysis catheters","volume":"49","author":"Vercaigne","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b37-0702185","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jac\/dki311","article-title":"Stability of heparin and physical compatibility of heparin\/antibiotic solutions in concentrations appropriate for antibiotic lock therapy","volume":"56","author":"Robinson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b38-0702185","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1523-1755.2002.00201.x","article-title":"Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution","volume":"61","author":"Krishnasami","year":"2002","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019031208581902900_b39-0702185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1797.2006.00563.x","article-title":"Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial","volume":"11","author":"Saxena","year":"2006","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t2019031208581902900_b40-0702185","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.ki.5001776","article-title":"Tunneled catheters\u2019 outcome optimization among diabetics on dialysis through antibiotic-lock placement","volume":"70","author":"Saxena","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019031208581902900_b41-0702185","first-page":"755","article-title":"The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study","volume":"18","author":"Saxena","year":"2005","journal-title":"J Nephrol"},{"issue":"1","key":"key\n\t\t\t\t2019031208581902900_b42-0702185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jac\/dkh488","article-title":"Treatment of long-term intravascular catheter related bacteraemia with antibiotic lock: randomized, placebo-controlled trial","volume":"55","author":"Rijnders","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b43-0702185","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/AAC.00147-11","article-title":"Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections","volume":"55","author":"Van Praagh","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b44-0702185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1742-1241.2011.02830.x","article-title":"Daptomycin lock therapy for grampositive long-term catheter-related bloodstream infections","volume":"66","author":"Del Pozo","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b45-0702185","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/AAC.01129-12","article-title":"Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm","volume":"57","author":"Estes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b46-0702185","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activity of daptomycin, linezolid and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b47-0702185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1469-0691.2001.00233.x","article-title":"Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique","volume":"7","author":"Capdevilla","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019031208581902900_b48-0702185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.diagmicrobio.2008.10.004","article-title":"Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections","volume":"63","author":"Del Pozo","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b49-0702185","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dks472","article-title":"In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and\/or heparin as lock solutions against embedded Acinetobacter baumannii strains","volume":"68","author":"Ozbek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b50-0702185","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.039743-0","article-title":"Comparative in vitro efficacies of ethanol, EDTA and levofloxacin based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms","author":"Passerini de Rossi","year":"2012","journal-title":"J Med Microbiol"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b51-0702185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1054\/clnu.2002.0541","article-title":"Prevention and treatment of implanted central venous catheter (CVC) \u2013 related sepsis: a report after six years of home parenteral nutrition","volume":"21","author":"Santarpia","year":"2002","journal-title":"Clin Nutr"},{"key":"key\n\t\t\t\t2019031208581902900_b52-0702185","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2146\/ajhp110256","article-title":"Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions","volume":"69","author":"LaPlante","year":"2012","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b53-0702185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.mat.0000183656.75618.09","article-title":"Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique","volume":"51","author":"Bastani","year":"2005","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019031208581902900_b54-0702185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10096-007-0356-7","article-title":"Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin","volume":"26","author":"Soriano","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b55-0702185","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ndt\/15.7.1035","article-title":"Insufficient penetration of systemic vancomycin into the PermaCath lumen","volume":"15","author":"Bastani","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019031208581902900_b56-0702185","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkl318","article-title":"Treatment of longterm intravascular catheter-related bacteraemia with antibiotic-lock therapy","volume":"58","author":"Fortun","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b57-0702185","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/ndt\/gfm141","article-title":"In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model","volume":"22","author":"Laplante","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b58-0702185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/infdis\/157.3.600","article-title":"A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities","volume":"157","author":"Henrickson","year":"1988","journal-title":"J Infect Dis"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b59-0702185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0148607192016003268","article-title":"Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections","volume":"16","author":"Yao","year":"1992","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"key\n\t\t\t\t2019031208581902900_b60-0702185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/01.inf.0000141740.82420.e6","article-title":"Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients","volume":"23","author":"De Sio","year":"1004","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2019031208581902900_b61-0702185","first-page":"593","article-title":"Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience","volume":"19","author":"Al-Hwiesh","year":"2008","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"key\n\t\t\t\t2019031208581902900_b62-0702185","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfs081","article-title":"Anti-microbial locks increase the incidence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study","author":"Dixon","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"key\n\t\t\t\t2019031208581902900_b63-0702185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/107815529700300103","article-title":"Formulation of a flush solution of heparin, vancomycin, and colistin for implantable access systems in oncology","volume":"3","author":"Vincentelli","year":"1997","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b64-0702185","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfh041","article-title":"Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen","volume":"19","author":"Poole","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"Pt 4","key":"key\n\t\t\t\t2019031208581902900_b65-0702185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1099\/jmm.0.006387-0","article-title":"Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms","volume":"58","author":"Qu","year":"2009","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t2019031208581902900_b66-0702185","unstructured":"Information for Healthcare Professionals: Linezolid (marketed as Zyvox). Food and Drug Administration Alert. [cited 2012 February 1]; Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHealthcareProfessionals\/ucm085249.htm."},{"key":"key\n\t\t\t\t2019031208581902900_b67-0702185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study","volume":"48","author":"Wilcox","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b68-0702185","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/AAC.47.10.3145-3148.2003","article-title":"Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections","volume":"47","author":"Curtin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b69-0702185","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002480-200011000-00021","article-title":"Adjunctive antibiotic\/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device","volume":"46","author":"Boorgu","year":"2000","journal-title":"ASAIO J"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b70-0702185","first-page":"328","article-title":"Cloxacillin as an antibiotic lock solution for prevention of catheter-associated infection","volume":"5","author":"Davanipur","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b71-0702185","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.50.5.1865-1868.2006","article-title":"Comparative in vitro efficacies of various catheter lock solutions","volume":"50","author":"Sherertz","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b72-0702185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/dkr477","article-title":"Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms","volume":"67","author":"Holmberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b73-0702185","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3201\/eid1709.101810","article-title":"Central venous catheter-associated Nocardia bacteremia in cancer patients","volume":"17","author":"Al Akhrass","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"key\n\t\t\t\t2019031208581902900_b74-0702185","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/AAC.00677-11","article-title":"Antimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infections","volume":"55","author":"Ghannoum","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b75-0702185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.00154-06","article-title":"Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b76-0702185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/344952","article-title":"Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer","volume":"36","author":"Chatzinikolaou","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019031208581902900_b77-0702185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/AAC.46.2.327-332.2002","article-title":"Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits","volume":"46","author":"Raad","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b78-0702185","volume-title":"Bioactivity of tetracycline antibiotic lock therapy in a model of catheter infection (abstract 475)","author":"Bookstaver"},{"key":"key\n\t\t\t\t2019031208581902900_b79-0702185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2009.04.011","article-title":"In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms","volume":"34","author":"Miceli","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t2019031208581902900_b80-0702185","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AEM.69.8.4814-4822.2003","article-title":"N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces","volume":"69","author":"Olofsson","year":"2003","journal-title":"Appl Environ. Microbiol"},{"key":"key\n\t\t\t\t2019031208581902900_b81-0702185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijantimicag.2010.06.034","article-title":"Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals","volume":"36","author":"Ku","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t2019031208581902900_b82-0702185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/502578","article-title":"A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access","volume":"26","author":"Bleyer","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019031208581902900_b83-0702185","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1086\/590192","article-title":"Pilot trial of N-acetylcysteine and tigecycline as a catheter lock solution for treatment of hemodialysis catheter-associated bacteremia","volume":"29","author":"Aslam","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t2019031208581902900_b84-0702185","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/AAC.48.9.3407-3411.2004","article-title":"Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations","volume":"48","author":"Stevens","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b85-0702185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2146\/ajhp070322","article-title":"Visual compatibility of caspofungin acetate with commonly used drugs during stimulated Y-site delivery","volume":"65,5","author":"Condie","year":"2008","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019031208581902900_b86-0702185","volume-title":"Stability and compatibility of candidate antifungal lock solutions of micafungin (abstract 134)","author":"Bookstaver"},{"key":"key\n\t\t\t\t2019031208581902900_b87-0702185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkf183","article-title":"Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis","volume":"50","author":"Bailey","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b88-0702185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijantimicag.2008.06.020","article-title":"Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm","volume":"32","author":"Raad","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"key\n\t\t\t\t2019031208581902900_b89-0702185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/dkr429","article-title":"Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms","volume":"67","author":"Nweze","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"key\n\t\t\t\t2019031208581902900_b90-0702185","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.01701-10","article-title":"Effects of fluconazole, amphotericin B, and caspofungin on Candida albican biofilms under conditions of flow and on biofilm dispersion","volume":"55","author":"Uppuluri","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b91-0702185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/112972980700800408","article-title":"Effect of ethanol\/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections","volume":"8","author":"Takla","year":"2007","journal-title":"J Vasc Access"},{"key":"key\n\t\t\t\t2019031208581902900_b92-0702185","unstructured":"Excelsior Medical. Excelsior Medical\u2019s New Catheter Lock Solution. Approved by Health Canada. www.excelsiormedical.com\/pdfs\/Health-Canada-2010.pdf (accessed 2012 July 7)."},{"key":"key\n\t\t\t\t2019031208581902900_b93-0702185","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00229-13","article-title":"Glyceryl Trinitrate Complements Citrate and Ethanol in Eradicating Biofilm Organisms: A Novel Antimicrobial Catheter Lock Solution","author":"Rosenblatt","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b94-0702185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhin.2006.01.009","article-title":"Ethanol disinfection of plasticadherent micro-organisms","volume":"63","author":"Chambers","year":"2006","journal-title":"J Hosp Infect"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b95-0702185","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2008.02.026","article-title":"Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome","volume":"43","author":"Mouw","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b96-0702185","doi-asserted-by":"crossref","first-page":"e10840","DOI":"10.1371\/journal.pone.0010840","article-title":"Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial","volume":"5","author":"Slobbe","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b97-0702185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.PCC.0000288711.46009.58","article-title":"Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial","volume":"8","author":"Filippi","year":"2007","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b98-0702185","doi-asserted-by":"crossref","first-page":"e32945","DOI":"10.1371\/journal.pone.0032945","article-title":"Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation","volume":"7","author":"Al Akhrass","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"key\n\t\t\t\t2019031208581902900_b99-0702185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jac\/dkp060","article-title":"Effect of a solution containing citrate\/Methylene Blue\/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions","volume":"63","author":"Sauer","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b100-0702185","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/ndt\/gfn776","article-title":"Microbial inactivation properties of a new antimicrobial\/antithrombotic catheter lock solution (citrate\/methylene blue\/parabens)","volume":"24","author":"Steczko","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"key\n\t\t\t\t2019031208581902900_b101-0702185","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCM.0b013e318206b5a2","article-title":"A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial","volume":"39","author":"Maki","year":"2011","journal-title":"Crit Care Med"},{"issue":"3","key":"key\n\t\t\t\t2019031208581902900_b102-0702185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000324685","article-title":"Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial","volume":"33","author":"Filiopoulos","year":"2011","journal-title":"Am J Nephrol"},{"issue":"12","key":"key\n\t\t\t\t2019031208581902900_b103-0702185","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1086\/375234","article-title":"Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution","volume":"36","author":"Allon","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b104-0702185","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/ndt\/gfh014","article-title":"Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution","volume":"19","author":"Betjes","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019031208581902900_b105-0702185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-8-102","article-title":"Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients","volume":"8","author":"Simon","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b106-0702185","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","article-title":"A randomized double-blid controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis","volume":"55","author":"Solomon","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"key\n\t\t\t\t2019031208581902900_b107-0702185","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.46.6.1674-1679.2002","article-title":"Antimicrobial activity of a novel catheter lock solution","volume":"46","author":"Shah","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031208581902900_b108-0702185","article-title":"A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients","author":"Zwiech","year":"2013","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t2019031208581902900_b109-0702185","unstructured":"TauroLock\u2122. Available at: http:\/\/www.taurolock.com (accessed 2013 Apr 1)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/70\/24\/2185\/28051268\/ajhp2185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:08:48Z","timestamp":1746061728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/70\/24\/2185\/5112406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,15]]},"references-count":109,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2013,12,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp120119","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,12,15]]},"published":{"date-parts":[[2013,12,15]]}}}